Wall Street's projections for the September 2014, third quarter earnings per share for Mylan Inc (NASDAQ:MYL) have seen a modification upward and now range from $0.90 to $1.15 per share with a consensus of $1.04 per share.
RECOMMENDATIONS
- The consensus recommendation is a buy.
- The recommendations from twenty analysts include seven strong buy, seven buy, five hold and one underperform.
- A buy is the average consensus recommendation for the Generic Drugs peer group.
FORECAST CHANGES
- Earnings estimates are currently provided to Thomson Reuters I/B/E/S by nineteen analysts.
- In the last week, one upward revision was made.
- During the last four weeks, eleven upward revisions were made.
- The consensus earnings per share estimate has increased from $0.94 per share during the last four weeks.
- High estimate four weeks ago was $1.03 and the low estimate was $0.90.
YEAR OVER YEAR
- Current quarter consensus estimate of $1.04 per share implies a change of 26.34% from the same quarter last year when the company earned $0.82 per share.
- Earnings for the peer group are expected to fall below the same quarter last year but have been scaled up over the last four weeks.
Mylan Inc (NASDAQ:MYL) shares are up 1.25% to $50.94 in early morning trade.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
